Dark

TEVA
Teva Pharmaceutical Industries Limited
stock NYSE ADR

At Close

May 23, 2025 3:59:59 PM EDT

16.95USD+0.059%(+0.01)6,476,389

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 23, 2025 9:26:30 AM EDT

16.75USD-1.122%(-0.19)10,466

After-hours

May 23, 2025 4:14:30 PM EDT

16.97USD+0.118%(+0.02)2,045

OverviewOptionsHistoricalExchangesShortsNews

Jan 27, 2022

10:04AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022 Benzinga

08:05AM EST Argus Research Downgrades Teva Pharmaceutical Indus to Hold Benzinga

Jan 18, 2022

08:00AM EST Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance at 8 a.m. ET on February 9, 2022 Business Wire

Jan 4, 2022

01:35PM EST Teva to Present at the 40th Annual J.P. Morgan Healthcare Conference Business Wire

Jan 3, 2022

06:22AM EST Teva Suffers Loss In New York's Opioid Trial Benzinga

Dec 30, 2021

09:42PM EST A New York jury ruled that Teva Pharmaceuticals USA and its affiliates were liable for the public nuisance charges made by New York state in its opioid trial in Suffolk County State Supreme Court. RTTNews

01:30PM EST Teva Issues Statement Following New York Jury Ruing In Opioids Trial (Full Statement) Benzinga

01:29PM EST Teva Statement Following New York Jury Ruling in Opioids Trial Business Wire

01:22PM EST New York Attorney General Says Teva Pharmaceuticals To Pay More On Top Of Already Negotiated $1.5B Benzinga

12:02PM EST U.S. Jury Finds Teva Pharmaceuticals Industries Fueled Opioid Epidemic; Verdict Does Not Include Damages Benzinga

Dec 27, 2021

10:16AM EST Teva Pharmaceuticals To Market Cannabis Oils From Cannabit-Tikun Olam In Israel, Palestine, Ukraine Benzinga

10:10AM EST NYSE Traded Teva Pharmaceuticals To Market Cannabis Oils From Cannabit-Tikun Olam In Israel, Palestine, Ukraine Benzinga

07:26AM EST Teva Signs Commercial And Exclusive Agreement Between 'Teva Israel' And 'Cannbit-Tikun Olam' - For Marketing And Distribution Of Medical Cannabis Oil; As Part Of Deal, Co.s To Collaborate For Extended Period Of 10 Years, Will Be Able To Extend By Another Benzinga

Dec 23, 2021

09:07AM EST Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table Benzinga

Dec 22, 2021

04:30PM EST Teva Highlights Launch Of Generic Version Of Narcan In US Benzinga

04:30PM EST Teva Announces Launch of First-to-Market Generic Version of Narcan(r) (Naloxone Hydrochloride Nasal Spray), in the U.S. Business Wire

Dec 1, 2021

08:23AM EST Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced the launch of an authorized generic of Epiduo Forte Gel, or adapalene and benzoyl peroxide gel 0.3%/2.5%, in the U.S. It is a topical prescription medicine used to treat acne vulgaris. RTTNews

08:12AM EST Teva Pharma Highlights Launch Of Authorized Generic Epiduo Forte Gel In US Benzinga

08:03AM EST Teva Announces Launch Of Authorized Generic Of Epiduo Forte Gel In U.S. RTTNews

08:00AM EST Teva Announces Launch of an Authorized Generic of Epiduo(r) Forte Gel (adapalene and benzoyl peroxide gel 0.3%/2.5%), in the U.S. Business Wire

Nov 30, 2021

04:38PM EST This Day In Market History: UN Partitions Palestine For Independent Jewish State Benzinga

Nov 25, 2021

12:00PM EST -- Quantum Genomics will receive up to $11 M in payments and 25% minimum up to 30% royalties on future sales -- Teva will receive an exclusive license to bring firibastat to its home market, Israel GlobeNewswire Inc

Nov 10, 2021

09:17AM EST Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement Business Wire

Nov 3, 2021

09:19AM EDT The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering Benzinga

06:00AM EDT Teva Becomes First Pharmaceutical Company to Execute Sustainability-linked Bond Tied to both Climate and Access to Medicine Targets Business Wire

Nov 2, 2021

05:31PM EDT Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5,000,000,000 of Sustainability-Linked Senior Notes Business Wire

Nov 1, 2021

10:42PM EDT Orange County, California, Superior Court Judge Peter Wilson ruled that Teva did not make any false or misleading statements in connection with marketing prescription opioids in California. The court also ruled that the company did not cause a public nuisance in Orange County, Los Angeles County, Santa Clara County and the City of Oakland, the company said in a statement on Monday. RTTNews

10:18PM EDT Teva Says California Judge Rules Company Did Not Cause Public Nuisance Or Make False Statements About Opioids RTTNews

10:00PM EDT California Judge Rules That Teva Did Not Cause a Public Nuisance or Make False or Misleading Statements About Opioids Business Wire

Oct 30, 2021

04:00PM EDT New Phase 3 Data Presented at Psych Congress 2021 Showed TV-46000/mdc-IRM Significantly Prolonged Time to Impending Relapse Compared to Placebo in Patients with Schizophrenia Business Wire

Oct 28, 2021

10:48AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021 Benzinga

07:21AM EDT Raymond James Downgrades Teva Pharmaceutical Indus to Market Perform Benzinga

Oct 27, 2021

12:08PM EDT Looking Into Teva Pharmaceutical Indus's Return On Capital Employed Benzinga

09:02AM EDT Teva Q3 Earnings Fall Short Of Expectations; Reaffirms FY21 Guidance Benzinga

08:39AM EDT From Teva Earnings Conference Call: CEO Says Won't Do Any M&A Deals Until Debt Is Reduced Further Benzinga

08:23AM EDT Teva Pharmaceutical Industries Ltd. (TEVA) reported an increase in adjusted profit for the third-quarter. However, the results missed Wall Street estimates. Revenues declined 2%, or 3% in local currency terms, mainly due to lower revenues in North America segment. RTTNews

07:23AM EDT Teva Plans To Offer $4 Bln Of Sustainability-linked Senior Notes RTTNews

07:15AM EDT Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes Business Wire

07:15AM EDT Teva Announces $3,500,000,000 Debt Tender Offers for Notes Due 2022-2024 Business Wire

07:06AM EDT Teva Q3 Revenues $3.887 Bln, Decrease Of 2% Or 3% In Local Currency Terms RTTNews

07:05AM EDT Teva Pharmaceutical Indus Q3 Adj. EPS $0.59 Misses $0.65 Estimate, Sales $3.89B Miss $4.03B Estimate; Reaffirms Guidance Benzinga

07:00AM EDT Teva Reports Third Quarter 2021 Financial Results Business Wire

03:43AM EDT Earnings Scheduled For October 27, 2021 Benzinga

Oct 26, 2021

04:48PM EDT Teva, Modag Report Licensing Collab For Neurodegenerative Disease Drug Candidate Benzinga

04:45PM EDT Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate Business Wire

Oct 21, 2021

08:00AM EDT Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021 Business Wire

Oct 13, 2021

01:38PM EDT Teva Pharmaceutical Industries European Affiliate Teva Pharmaceuticals Europe BV Announced New Safety Data On Treatment With COPAXONE Of Breastfeeding Mothers Who Live With Relapsing Multiple Sclerosis Benzinga

Oct 6, 2021

08:15AM EDT Bitcoin Is The Ferrari And Gold Is The Horse And Buggy, According To Bill Miller Benzinga

Oct 4, 2021

02:43PM EDT Teva Stops Production At US Plant After FDA Concerns: Report Benzinga

07:54AM EDT Teva Pharm Says Has Temporarily Stopped The Manufacture Of Products From Its Irvine, CA Facility; Says Conducting A Thorough Review Of Irvine Facility After Recent FDA Inspection Benzinga

Oct 1, 2021

10:20AM EDT Teva to Host Conference Call to Discuss Third Quarter 2021 Financial Results at 8 a.m. ET on October 27, 2021 Business Wire

Sep 30, 2021

08:00AM EDT Teva to Present 8 Abstracts on AJOVY(r) (fremanezumab-vfrm) Injection and Hold Symposium on Healthcare Disparities at WCN Business Wire

07:33AM EDT Teva Pharma Announces Launch Of Inhaler Tales Campaign RTTNews

07:30AM EDT Teva Enlists Sarah Michelle Gellar to Launch "Inhaler Tales" Campaign to Raise Awareness About Inhaler Use in Asthma and COPD Business Wire

Sep 28, 2021

12:42PM EDT UPDATE: Teva Will Pay Louisiana $15M Over 18-Year Time Period Benzinga

12:40PM EDT Teva Reaches Agreement With Louisiana To Settle State's Opioid-Related Claims Benzinga

Sep 20, 2021

10:32AM EDT Teva Partner Alvotech Announces FDA Is Deferring Action On application For AVT02 Benzinga

Sep 8, 2021

08:28AM EDT Teva Pharmaceutical Industries Ltd. (TEVA) said that late-breaking data at the international headache society & european headache federation joint congress 2021 showed Ajovy (fremanezumab-vfrm) injection reduced more monthly migraine days in a network meta-analysis study with atogepant and rimegepant. RTTNews

08:11AM EDT Teva Sees Migraine Treatment Landscape Continue To Advance; Data To Be Presented At Joint Congress 2021 On Sept 8-12 RTTNews

08:00AM EDT Late-Breaking Data at the International Headache Society & European Headache Federation Joint Congress 2021 Showed AJOVY(r) (fremanezumab-vfrm) Injection Reduced More Monthly Migraine Days in a Network Meta-Analysis Study with Atogepant and Rimegepant Business Wire

Sep 1, 2021

07:49AM EDT Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review Benzinga

07:32AM EDT The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering Benzinga

07:27AM EDT Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review Benzinga

Aug 31, 2021

04:31PM EDT Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), and MedinCell (MEDCL) Tuesday said that the New Drug Application for TV-46000/mdc-IRM for the treatment of schizophrenia has been accepted by the U.S. Food and Drug Administration. RTTNews

04:17PM EDT Teva, MedinCell Announce FDA Acceptance Of New Drug Application For TV-46000/mdc-IRM As A Treatment For Patients With Schizophrenia Benzinga

Aug 30, 2021

08:00AM EDT Showcasing Teva's Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be presented, Including One Late-Breaker, on AJOVY(r) (fremanezumab-vfrm) Injection at the International Headache Society and European Headache... Business Wire

Aug 20, 2021

08:11AM EDT Teva Announces Analysis Of Long-Term Data Examining Treatment With AUSTEDO Tablets In Adult With Tardive Dyskinesia RTTNews

08:02AM EDT Teva Reports Post Hoc Analysis Of Long-Term Data Examining Treatment With AUSTEDO Tablets In Adult Patients With Tardive Dyskinesia Benzinga

08:00AM EDT Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO(r) (deutetrabenazine) Tablets in Adult Patients with Tardive Dyskinesia Business Wire

Aug 11, 2021

07:55AM EDT WHO Says Solidarity Clinical Trial Enters New Phase With Three New Candidate Drugs For Treating COVID-19; Artesunate, Imatinib And Infliximab Were Selected By An Independent Expert Panel For Potential In Reducing The Risk Of Death In Hospitalized Patients Benzinga

Jul 29, 2021

08:26AM EDT Raymond James Maintains Outperform on Teva Pharmaceutical Indus, Lowers Price Target to $14 Benzinga

07:43AM EDT Wells Fargo Maintains Equal-Weight on Teva Pharmaceutical Indus, Lowers Price Target to $11 Benzinga

Jul 28, 2021

10:56AM EDT Shares of Teva Pharmaceutical Industries Ltd. (TEVA) are gaining over 10% on Wednesday morning after the pharma giant reported its second-quarter results and updated its outlook. RTTNews

07:36AM EDT Independent Analysis Says Teva Generic Medicines Saved U.S. $28.8 Bln In 2020, Total Of $43.1 Bln Across Major Markets RTTNews

07:33AM EDT The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal Benzinga

07:30AM EDT Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis Business Wire

07:27AM EDT Teva Lowers FY Revenues Outlook RTTNews

07:24AM EDT Recap: Teva Pharmaceutical Q2 Earnings Benzinga

07:12AM EDT Teva Sees FY21 Adj. EBITDA $4.8B-$5.1B, EPS $2.50-$2.70 vs $2.45 Estimate Benzinga

07:12AM EDT Teva Pharmaceutical Industries Limited (TEVA) released earnings for its second quarter that climbed from last year. RTTNews

07:12AM EDT UPDATE: Teva Cuts FY21 Sales Guidance From $16.4B-$16.8B To $16B-$16.4B vs $16.55B Estimate Benzinga

07:11AM EDT Teva Pharmaceutical Indus Q2 EPS $0.59, Inline, Sales $3.91B Miss $4.04B Estimate; Cuts Guidance Benzinga

07:05AM EDT Teva Q2 GAAP EPS $0.19; Non-GAAP EPS $0.59 RTTNews

07:00AM EDT Teva Reports Second Quarter 2021 Financial Results Business Wire

04:27AM EDT Earnings Scheduled For July 28, 2021 Benzinga

Jul 21, 2021

08:00AM EDT Teva Announces Changes to Executive Management Team Business Wire

Jul 20, 2021

10:10AM EDT AmerisourceBergen (ABC), Cardinal Health (CAH) and McKesson (MCK) agreed to pay up to $1.179 billion in a settlement with the State of New York and its participating subdivisions, including Nassau and Suffolk Counties, to settle opioid-related claims. RTTNews

Jul 2, 2021

11:46AM EDT Teva Recalls One Batch Of Topotecan After Complaint Of Glass Particulate In Vial Benzinga

03:56AM EDT Teva Pharmaceuticals has recalled a single lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) due to presence of particulate matter, the U.S. Food and Drug Administration said. RTTNews

Jul 1, 2021

12:14PM EDT Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021 Business Wire

Jun 29, 2021

03:25PM EDT New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid Benzinga

Jun 28, 2021

11:07AM EDT JNJ's $260M Settlement Could Serve As Global Opioid Deal Template: Analyst Benzinga

08:14AM EDT Teva Pharmaceutical Industries Ltd. (TEVA) said that it reached a strategic partnership for the exclusive commercialization of Bioeq's FYB201, a biosimilar candidate to Lucentis (ranibizumab) in Europe, Canada, Israel and New Zealand. RTTNews

08:07AM EDT Teva And Bioeq Announce Commercial Partnership For FYB201; Financial Terms Not Disclosed Benzinga

08:05AM EDT Teva And Bioeq Enter Deal For Commercialization Of FYB201 In Europe, Canada, Israel And New Zealand RTTNews

08:00AM EDT Teva and Bioeq Announce Commercial Partnership for Biosimilar Business Wire

Jun 26, 2021

05:16PM EDT Johnson & Johnson Reaches $230M Settlement With New York To End Sale Of Opioids Nationwide Benzinga

04:37PM EDT Johnson & Johnson Reaches $230M Settlement With New York State To End Sale Of Opioids Nationwide Benzinga

Jun 23, 2021

08:36AM EDT Teva Pharmaceutical Industries Ltd. (TEVA) said Wednesday that Japan's Ministry of Health, Labour and Welfare has approved the use of AJOVY or fremanezumab injection for the preventive treatment of migraine in adults. RTTNews

08:17AM EDT Teva: Ministry Of Health, Labour And Welfare Approves AJOVY Injection In Japan RTTNews

08:14AM EDT Teva Announces Ministry Of Health, Labour And Welfare Approves AJOVY Injection In Japan For Preventive Treatment Of Migraine In Adults Benzinga

08:12AM EDT Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY(r) (fremanezumab) Injection in Japan for the Preventive Treatment of Migraine in Adults Business Wire

Jun 22, 2021

05:19PM EDT Teva Announces Its Launch Of Generic PERFOROMIST, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used To Treat Chronic Obstructive Pulmonary Disease (COPD), In The U.S. Benzinga

05:18PM EDT Teva Announces Its Launch of the First Generic PERFOROMIST(r), Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD), in the United States Business Wire

Jun 21, 2021

05:24PM EDT Exelixis 8-K Shows. Co. Received Notice Letters From Teva Related To Abbreviated New Drug Application For CABOMETYX Tablets; Co. Filed Complaint In US For Patent Infringement Against Teva Benzinga

08:03AM EDT Teva Highlights New Analysis Presented By Co. On AJOVY Injection For Prentative Measure Of Migraine Benzinga

Jun 18, 2021

09:00AM EDT Teva Pharmaceutical Shares Quiet; Israel To Transfer ~1M-1.4M Vaccine Doses To Palestinian Authority Through Co Benzinga

Jun 16, 2021

07:49AM EDT Teva Pharmaceuticals, a U.S. affiliate of Israeli generic drug maker Teva Pharmaceutical Industries Ltd. (TEVA), announced Wednesday the U.S. launch of its generic version of once daily Soolantra (ivermectin) Cream, 1% for the treatment of inflammatory lesions of rosacea. RTTNews

07:38AM EDT Teva Announces U.S. Launch Of Its Generic Version Of Once daily SOOLANTRA Or Ivermectin Cream, 1% RTTNews

07:36AM EDT Teva Announces the U.S. Launch of its Generic Version of SOOLANTRA(r) (ivermectin) Cream, 1% for Once Daily Treatment of Rosacea Business Wire

Jun 4, 2021

07:22AM EDT Teva Pharmaceuticals USA Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new data from clinical and real-world analyses examining the efficacy of AJOVY or fremanezumab-vfrm for the treatment of migraine. It will be presented at the American Headache Society (AHS) annual meeting, taking place virtually on June 3-6. RTTNews

Jun 3, 2021

08:23AM EDT Teva Pharma Presents New Data From Clinical And Real-world Analyses Examining The Efficacy Of AJOVY For Migraine At ASH RTTNews

08:19AM EDT Teva To Present AJOVY Data At 2021 American Headache Society Annual Meeting Benzinga

08:15AM EDT New Clinical and Real-World Data Evaluating Efficacy of AJOVY(r) (fremanezumab-vfrm) Injection Presented at 2021 American Headache Society (AHS) Annual Meeting Business Wire

08:07AM EDT Teva To Present Latest Data On AJOVY Injection At 2021 AHS Annual Meeting RTTNews

08:00AM EDT Teva to Present Latest Data on AJOVY(r) (fremanezumab-vfrm) Injection at the 2021 American Headache Society (AHS) Annual Meeting, Showcasing Teva's Longstanding Heritage in the Management of Migraine Business Wire

May 27, 2021

08:24AM EDT The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs Benzinga

May 17, 2021

01:03PM EDT Teva Highlights Launch Of First Available Generic Version Of THIOLA Tablets In US Benzinga

01:03PM EDT Teva Announces the U.S. Launch of the First Generic Version of THIOLA(r) (tiopronin) tablets Business Wire

08:34AM EDT Teva has launched 'It's Not OK - It's TD' national television advertising campaign to increase awareness of tardive dyskinesia and austedo or deutetrabenazine tablets. The Campaign kicks off during mental health awareness month and on the heels of tardive dyskinesia or TD week. RTTNews

08:12AM EDT Teva Pharma Announced The Launch Of It's Not OK - It's TD, A New National Television Advertising Campaign RTTNews

08:01AM EDT to Increase Awareness of Tardive Dyskinesia and AUSTEDO(r) (deutetrabenazine) tablets PR Newswire

May 10, 2021

08:00AM EDT Teva to Highlight Research in Respiratory Care at Upcoming 2021 American Thoracic Society International Conference Business Wire

May 5, 2021

08:00AM EDT Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report Business Wire

May 4, 2021

11:15AM EDT Teva Announces Launch Of Generic Erythromycin Tablets USP, For Treating, Preventing 'A Variety Of Bacterial Infections' In U.S. Benzinga

11:14AM EDT Teva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in the United States Business Wire

10:09AM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2021 Benzinga

07:23AM EDT UBS Downgrades Teva Pharmaceutical Indus to Neutral, Lowers Price Target to $11 Benzinga

May 3, 2021

08:19AM EDT Teva To Present New Long-Term AUSTEDO Tablets Data At American Psychiatric Association Annual Meeting Benzinga

08:13AM EDT Teva Pharma To Present Data From 3-yr Open-label Extension RTTNews

08:04AM EDT Teva Announces New Data From 3-year Open-label Extension study Of AUSTEDO Tablets RTTNews

08:00AM EDT Teva to Present New Long-Term AUSTEDO(r) (deutetrabenazine) Tablets Data at American Psychiatric Association Annual Meeting Business Wire

Apr 29, 2021

05:07PM EDT Teva Announces Launch Of Generic Version Of Absorica (Isotretinoin) Capsules In US Benzinga

04:18PM EDT Teva Announces the Launch of the First Generic Version of Absorica(r) (isotretinoin) Capsules, for the Treatment of Severe Recalcitrant Nodular Acne in Patients 12 Years of Age and Older, in the United States Business Wire

Apr 28, 2021

02:29PM EDT Major COVID-19 Vaccine Makers Reject Teva Pharmaceutical's Offer For Jab Manufacture Help: FT Benzinga

07:23AM EDT Teva Pharmaceutical Industries Limited (TEVA) announced a profit for its first quarter that rose from the same period last year. RTTNews

07:22AM EDT Recap: Teva Pharmaceutical Q1 Earnings Benzinga

07:09AM EDT Teva Sees FY21 EPS $2.50-$2.70 Vs. $2.61 Est., Sales $16.4B-$16.8B Vs. $16.68B Est. Benzinga

07:08AM EDT Teva Pharmaceutical Indus Q1 EPS $0.63 Beats $0.59 Estimate, Sales $4.00B Miss $4.02B Estimate Benzinga

07:04AM EDT Teva Pharma Q1 GAAP Net Income Attributable To Teva $77 Mln Or $0.07/Shr Vs $69 Mln Or $0.06/Shr Last Year RTTNews

07:00AM EDT Teva Reports First Quarter 2021 Financial Results Business Wire

04:15AM EDT Earnings Scheduled For April 28, 2021 Benzinga

Apr 27, 2021

08:07AM EDT Teva to Present New Analyses of AUSTEDO Tablets and Assessment of Schizophrenia Clinical Outcomes at Upcoming 2021 American Psychiatric Association Annual Meeting Benzinga

08:05AM EDT Teva To Highlight Long-term Efficacy, Safety, And Tolerability Data From The Pivotal ARM-TD And AIM-TD Clinical Trials RTTNews

08:00AM EDT Teva to Present New Analyses of AUSTEDO(r) (deutetrabenazine) Tablets and Assessment of Schizophrenia Clinical Outcomes at Upcoming 2021 American Psychiatric Association Annual Meeting Business Wire

Apr 23, 2021

11:09AM EDT Teva Announces Launch of its Generic Version of Canasa(r) (mesalamine) Suppositories To Treat Adults with Active Ulcerative Proctitis (ulcerative rectal colitis), in the United States Business Wire

Apr 19, 2021

09:15AM EDT Teva Pharma Reports Real-World Data Evaluating Efficacy Of RTTNews

08:18AM EDT Teva Pharmaceuticals Says New Clinical, Real-World Data Evaluating Efficacy Of AJOVY Injection And Reduction Of Migraine Burden Presented At 2021 American Academy Of Neurology Virtual Meeting Benzinga

08:07AM EDT Teva Announces New Data From Clinical And Real-world Analyses Examining Efficacy Of AJOVY RTTNews

08:00AM EDT New Clinical and Real-World Data Evaluating Efficacy of AJOVY(r) (fremanezumab-vfrm) Injection and Reduction of Migraine Burden Presented at 2021 American Academy of Neurology Virtual Annual Meeting Business Wire

Apr 15, 2021

08:09AM EDT Teva to Present New Analyses of AJOVY Injection and AUSTEDO Tablets at Upcoming 2021 American Academy of Neurology Virtual Annual Meeting, Highlighting Teva's Ongoing Commitment to Neurology Benzinga

08:05AM EDT Teva To Present New Analyses Of AJOVY Injection And AUSTEDO Tablets RTTNews

08:00AM EDT Teva to Present New Analyses of AJOVY(r) (fremanezumab-vfrm) Injection and AUSTEDO(r) (deutetrabenazine) Tablets at Upcoming 2021 American Academy of Neurology Virtual Annual Meeting, Highlighting Teva's Ongoing Commitment to Neurology Business Wire

Apr 14, 2021

09:13AM EDT UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots Benzinga

Apr 12, 2021

02:43PM EDT South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report Benzinga

Apr 8, 2021

12:38PM EDT Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC Benzinga

07:34AM EDT Teva Canada Announces New Autoinjector for AJOVY for the Preventive Treatment of Migraine in Adults Benzinga

Apr 7, 2021

11:16AM EDT Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots Benzinga

Apr 6, 2021

09:42AM EDT Teva to Host Conference Call to Discuss First Quarter 2021 Financial Results at 8 a.m. ET on April 28, 2021 Business Wire

Mar 31, 2021

02:27PM EDT EMA May Issue Updated Recommendation If AstraZeneca Jab-Clot Link Is Established: Report Benzinga

07:09AM EDT Pfizer-BioNTech's COVID-19 Vaccine Gives 100% Protection In Adolescents Benzinga

Mar 29, 2021

07:23AM EDT White House Contemplates Waiving-Off Patent Protections For COVID-19 Treatments Benzinga

Mar 22, 2021

06:11AM EDT AstraZeneca's COVID-19 Shot Shows 79% Efficacy In US Trials Benzinga

Mar 17, 2021

12:40PM EDT Pfizer/BioNTech COVID-19 Vaccination Could Protect Pregnant Women, Newborns, Study In Israel Suggests: Reuters Benzinga

12:05PM EDT Teva Pharmaceutical Indus Option Alert: Jun 18 $12 Calls Sweep (37) near the Ask: 699 @ $1.0 vs 35463 OI; Earnings 5/6 Before Open [est] Ref=$11.44 Benzinga

Mar 15, 2021

02:11PM EDT Germany, France Join List Of Countries Suspending AZN's COVID-19 Vaccine; WHO Urges Not To Halt Vaccinations Benzinga

Mar 12, 2021

11:32AM EST Teva Block Trade Of 7.4M Shares At $10.75/Share Benzinga

Mar 10, 2021

05:47AM EST Pfizer, BioNTech Predict Increase In Capacity To 3B COVID-19 Vaccine Shots In 2022: Bloomberg Benzinga

Mar 8, 2021

02:52PM EST Teva Announces Launch Of First Generic Version Of AZOPT 1% Used To Treat High Pressure Inside The Eye In The U.S. Benzinga

02:46PM EST Teva Announces Launch of First Generic Version of AZOPT(r) (brinzolamide ophthalmic suspension) 1%, used to treat high pressure inside the eye, in the United States Business Wire

Mar 5, 2021

09:01AM EST WHO, SII Warn Of Raw Materials Shortage For COVID-19 Shots, Cites US Law As 'Serious' Limit:' Bloomberg Benzinga

Mar 4, 2021

09:13AM EST The European Commission has opened a formal antitrust investigation against Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd. (TEVA) to assess whether it has illegally delayed the market entry and uptake of medicines that compete with its blockbuster multiple sclerosis drug Copaxone. RTTNews

08:37AM EST Novartis Lends Support To Manufacture CureVac's COVID-19 Shots Benzinga

08:33AM EST EU Probes Possible Anticompetitive Conduct Of Teva In Relation To Multiple Sclerosis Medicine RTTNews

06:36AM EST Teva Pharm On EU Probe: We Do Not Believe That Teva Adopted Anti-competitive Behaviors In Relation To Copaxone And We Are Cooperating Fully With The Commission Benzinga

06:08AM EST Emergent BioSolutions Capable Of Manufacturing 1B COVID-19 Vaccine Doses Annually, CEO Says Benzinga

05:47AM EST European Commission Begins Antitrust Investigation into Teva's Multiple-Sclerosis Drug Copaxone, Concerning Possible Abuse of Dominant Market Position Benzinga

Mar 3, 2021

07:13AM EST EU Considers Emergency Approvals To Boost COVID-19 Vaccine Rollout: Reuters Benzinga

Mar 2, 2021

12:26PM EST European Officials Seek To Garner Support For AstraZeneca COVID-19 Shot: CNBC Benzinga

09:13AM EST Merck To Offer Hand With JNJ COVID-19 Vaccine Production, Biden Administration Says: Report Benzinga

08:45AM EST People Allergic To Pfizer, Moderna COVID-19 Vaccine Might Be Allowed To Get JNJ Shot: CNBC Benzinga

05:51AM EST AstraZeneca, Pfizer/BioNtech Single Shot COVID-19 Jab 80% Effective At Preventing Hospitalizations In Elderly Benzinga

05:15AM EST Novavax Bullish On Potential FDA EUA Nod For COVID-19 Vaccine By May Benzinga

Mar 1, 2021

04:00PM EST Teva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance Conference Business Wire

Feb 26, 2021

08:05AM EST Teva : New Study Published In Cephalalgia Identifies Mechanistic Differences Among CGRP Migraine Treatments RTTNews

08:04AM EST Teva Highlights Publication Of Study In Cephalalgia Identifying 'Mechanistic Differences Among CGRP Migraine Treatments' Benzinga

08:00AM EST New Study Published in Cephalalgia Identifies Mechanistic Differences Among CGRP Migraine Treatments Business Wire

07:17AM EST Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg Benzinga

Feb 25, 2021

05:50AM EST Moderna Raises 2021 Base COVID-19 Vaccine Production Plan To 700M Doses Benzinga

05:42AM EST Moderna To Test New COVID-19 Vaccine Targeting South Africa Strain Benzinga

Feb 23, 2021

06:40AM EST FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants Benzinga

Feb 22, 2021

07:14AM EST Sanofi/GlaxoSmithKline Initiate COVID-19 Vaccine Development After Setback Benzinga

Feb 18, 2021

07:26AM EST Pfizer Says South African Variant Could Significantly Reduce Vaccine Protection: Reuters Benzinga

Feb 17, 2021

06:46AM EST Shortage Of Giant Sterile Liners Threatens Global Vaccines Rollout: FT Benzinga

Feb 10, 2021

01:07PM EST 'Teva Pharm in talks to co-produce COVID-19 vaccines, CEO says' -Reuters, From Earlier Benzinga

10:24AM EST Teva Pharmaceuticals shares were trading higher after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY21 guidance. Benzinga

08:40AM EST Teva CEO Says Co. Close To Settlement On Opioid Case Benzinga

08:38AM EST Teva Says Expects Q1 To Be Weakest Sales Quarter And Gradually Rise Throughout 2021 Benzinga

07:34AM EST The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs Benzinga

07:25AM EST Teva Pharmaceuticals Sees FY21 EPS $2.50-$2.70 Vs. $2.63 Est., Sales $16.4B-$16.8B Vs. $16.76B Est. Benzinga

07:24AM EST Teva Pharmaceutical Indus Q4 EPS $0.68 Beats $0.63 Estimate, Sales $4.45B Beat $4.37B Estimate Benzinga

07:17AM EST While reporting its financial results for the fourth quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) forecast fiscal 2021 revenues in a range of $16.4 billion to $16.8 billion, and adjusted earnings per share in a range of $2.50 to $2.70. This compares to revenues of $16.7 billion and adjusted earnings per share of $2.57 per share for fiscal 2020. RTTNews

07:16AM EST Recap: Teva Pharmaceutical Q4 Earnings Benzinga

07:07AM EST Teva Pharmaceutical Industries Limited (TEVA) revealed earnings for its fourth quarter that advanced from last year. RTTNews

07:04AM EST Teva Q4 Revenues $4.454 Bln Flat With Last Year RTTNews

07:00AM EST Teva Reports Fourth Quarter and Full Year 2020 Financial Results Business Wire

03:43AM EST Earnings Scheduled For February 10, 2021 Benzinga

Feb 9, 2021

11:24AM EST Teva Pharmaceuticals Wins New Hearing On $235M GSK Patent Verdict Benzinga

Jan 15, 2021

07:57AM EST The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges Benzinga

Jan 14, 2021

05:18PM EST Teva Announces Launch Of A Generic Version Of NuvaRing Vaginal Ring In The U.S. Benzinga

05:17PM EST Teva Announces Launch of a Generic Version of NuvaRing(r) (etonogestrel and ethinyl estradiol) Vaginal Ring in the United States Business Wire

Jan 8, 2021

03:01PM EST Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021 Business Wire

Jan 7, 2021

04:00PM EST Teva to Present at the 39th Annual J.P. Morgan Healthcare Conference Business Wire

08:06AM EST Teva And MedinCell Announce Positive Results For Study TV46000-CNS-30072 RTTNews

08:04AM EST Teva And MedinCell Announce Phase 3 RISE Study Evaluating TV-46000/mdc-IRM Met Primary Endpoint Benzinga

08:00AM EST Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia Business Wire

Jan 5, 2021

12:59PM EST Jon Najarian Sees Unusual Option Activity In Target And Teva Benzinga

Dec 28, 2020

02:11PM EST Drugmakers have agreed to cut prices by around 50% for 119 medicines in order to have them included in China's state medical insurance scheme from March. RTTNews

Dec 1, 2020

07:38AM EST Ruling In Tris-Teva Case Prevents Activis From Launching Generic Versions Of Quillivant Xr Until Expiration Of Patent Providing Exclusivity Until Feb 2031 Benzinga

07:37AM EST 'Tris Pharma Wins Patent Case Over Copycat ADHD Drug by Teva Unit' -Bloomberg, From Monday Benzinga

Nov 25, 2020

09:51AM EST Oppenheimer Initiates Coverage On Teva Pharmaceutical Indus with Perform Rating Benzinga

Nov 18, 2020

04:16PM EST UPDATE: US Patent Trademark Office Doc On Teva v. Corcept Shows Determination 'there was a reasonable likelihood that Petitioner would prevail in showingthat at least' Benzinga

04:15PM EST Traders Circulate Nov. 18 Dated USPTO Court Document On Teva v Corcept (Link To Document) Benzinga

Nov 14, 2020

03:20PM EST Industries Limited Investors of the Important November 23 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVA PR Newswire

Nov 10, 2020

03:10PM EST ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Teva Pharmaceuticals GlobeNewswire Inc

Nov 6, 2020

02:34PM EST Stocktwits Trending Stocks For Friday, Nov. 6, 2020: ACB, SQ, TLRY, MAXR, TEVA, CRON, PLTR, UBER, AYX, CVS Benzinga

09:06AM EST BMO Capital Maintains Market Perform on Teva Pharmaceutical Indus, Lowers Price Target to $11 Benzinga

Nov 5, 2020

11:42AM EST Yahoo Finance Trending Stocks For Thursday, Nov. 5, 2020: QCOM, XPEV, UPWK, ACB, BIIB, GM, KXIN, FROG, HOFV, BLUE, TEVA, LIN, TLRY, HBI, PLTR, OPTI, CLVS, ZNGA, APHA, BABA, ALTM, GOLD, MFA, IIVI, PING, ACB, QRVO, ESALY Benzinga

08:47AM EST Teva Pharm CEO Schultz Says Optimistic Will See Single Digit Revenue Growth In Coming Years Benzinga

07:28AM EST Teva Sees FY20 EPS $2.40-$2.55 vs $2.51 Estimate, Net Sales $16.5B-$16.8B vs $16.69B Est. Benzinga

07:27AM EST Teva Pharmaceutical Indus Earlier Reported Q3 Adj. EPS $0.58, Inline, Sales $3.98B Miss $4.07B Estimate Benzinga

07:07AM EST Teva Q3 Non-GAAP EPS $0.58 RTTNews

07:00AM EST Teva Reports Third Quarter 2020 Financial Results Business Wire

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Nov 4, 2020

06:16PM EST Notable Earnings Watchlist For Thursday, Nov. 5, 2020 Before Market Open: MUR, ODP, WRK, REGN, ZTS, BLL, CAH, CIR, CBB, ABC, AGIO, AKBA, CMLS, AZN, HBI, CPRI, CNP, CNHI, CRON, GM, HII, NYT, PPL, MLCO, TEVA, BMY, BABA, AAWW, DUK, AMRN, CI, BDX Benzinga

Nov 3, 2020

06:15PM EST ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Teva Pharmaceuticals GlobeNewswire Inc

09:16AM EST McKesson Says Under Framework Proposed By Attorneys General, Three Largest U.S. Pharma Distributors Could Be Excepted To Pay Up To $21B Over 18 Years For Opioid-Related Settlement; Co Could Be Expected To Pay Up To About $8B Over 18 Years Benzinga

Oct 31, 2020

11:27PM EDT Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline - TEVA PR Newswire

Oct 30, 2020

08:41PM EDT Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVA PR Newswire

Oct 27, 2020

01:24PM EDT Israeli Cannabis Co. Univo Will Enter The U.K. Market Benzinga

Oct 23, 2020

05:45PM EDT ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Teva GlobeNewswire Inc

Oct 21, 2020

08:13AM EDT Teva Respiratory, LLC, An Affiliate of Teva Pharmaceutical Industries Announces Collaboration With Amazon Web Services and Onica To Build And Host Its Digital Health Platform Benzinga

08:05AM EDT Teva Collaborates With Amazon Web Services And Onica To Build And Host Digital Health Platform RTTNews

08:00AM EDT Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva's Digihaler(r) Portfolio Business Wire

Oct 20, 2020

09:04AM EDT Cramer Gives His Opinion On Cloudera, Barrick Gold And More Benzinga

Oct 17, 2020

06:41PM EDT Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline - TEVA PR Newswire

Oct 15, 2020

05:45PM EDT Industries Limited Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVA PR Newswire

07:30AM EDT - Senior Biopharm Executive with 20 Years of Immuno-Inflammatory Disease Therapeutic Experience - GlobeNewswire Inc

Oct 13, 2020

08:00AM EDT SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with GlobeNewswire Inc

Oct 12, 2020

10:39AM EDT ROSEN, A TOP RANKED LAW FIRM, Reminds Teva Pharmaceuticals GlobeNewswire Inc